Team:TU-Delft/Notebook/2013/06/06/

From 2013.igem.org

(Difference between revisions)
(6 of June)
 
(3 intermediate revisions not shown)
Line 3: Line 3:
{{:Team:TU-Delft/Templates/Frog}}
{{:Team:TU-Delft/Templates/Frog}}
{{:Team:TU-Delft/Templates/Logo}}
{{:Team:TU-Delft/Templates/Logo}}
-
 
+
{{:Team:TU-Delft/Templates/LabNotes}}
Line 11: Line 11:
 +
<html>
 +
<a name="lab1"></a>
 +
</html>
==6 of June==
==6 of June==
<br>
<br>
Line 18: Line 21:
<html>
<html>
<div style="margin-left:50px;margin-right:50px;float:left;display:inline-block;">   
<div style="margin-left:50px;margin-right:50px;float:left;display:inline-block;">   
-
<p align="justify">Today, we chose our final peptides after a long time research. In particular, we went through the literature in order to find
+
<p align="justify">Today, we chose the peptides to use after a long time of literature research. We chose the peptides according the criteria we described <a href="https://2013.igem.org/Team:TU-Delft/Peptides" target="blank">here</a> and below:</p>
-
peptides that satisfy the aforementioned criteria:</p>
+
</br>
</br>
<ol>
<ol>
<li>No postranslational modification</li>
<li>No postranslational modification</li>
-
<li>Do not affect E.Coli</li>
+
<li>Does Affect S. Aureus</li>
-
<li>Affect S. Aureus</li>
+
<li>Does not affect E.Coli</li>
-
<li>No possibility to be dangerous for human (based on MIC concentration)</li>
+
<li>Low toxicity for human</li>
</ol>
</ol>
</br>
</br>
Line 32: Line 34:
<ol>
<ol>
<li>Magainin</li>
<li>Magainin</li>
-
<li>Maxim</li>
+
<li>Maximin H5</li>
<li>Signiferin</li>
<li>Signiferin</li>
</html>
</html>

Latest revision as of 07:53, 4 October 2013

Notebook

June
SunMonTueWedThuFriSat
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30
July
SunMonTueWedThuFriSat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31










August
SunMonTueWedThuFriSat
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
September
SunMonTueWedThuFriSat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30











6 of June


Finaly Chosen Peptides

Today, we chose the peptides to use after a long time of literature research. We chose the peptides according the criteria we described here and below:


  1. No postranslational modification
  2. Does Affect S. Aureus
  3. Does not affect E.Coli
  4. Low toxicity for human

The list with the final peptides is:
  1. Magainin
  2. Maximin H5
  3. Signiferin